Patient support programmes generate vast amounts of data, but the real question is whether that data can drive meaningful action and genuine improvement. Many organisations collect and report on patient support metrics
Crystal Carey, General Counsel of the National Labor Relations Board, has released her clearest statement yet on which Biden-era rulings she intends to challenge or overturn. GC Memorandum 26-04, titled “Further Guidance
More
BAE Systems (LSE: BA) may not offer the highest yield in the FTSE 100, but its long track record of dividend growth makes it a standout income stock. A high dividend yield
More
Herbert Smith Freehills Kramer has strengthened its position among the leading advisers to FTSE 250 companies, climbing the client rankings in a competitive legal market. The firm’s rise reflects growing demand among
More
UCB’s Bimzelx emerged as a notable newcomer in August’s pharmaceutical television advertising rankings, claiming ninth place among the top spending drug brands. The psoriasis and psoriatic arthritis medication displaced Intra-Cellular Therapies’ Caplyta
More
Federal regulators have moved to clear up widespread confusion among financial institutions about what they can legally say to customers regarding suspicious account activity. FinCEN and four federal banking agencies issued a
More
In a remarkable turn, a former United States president has returned to the Supreme Court to personally argue a legal case before the nation’s highest bench. The appearance marks an extraordinary moment
More
The information technology sector saw notable price movements across twelve stocks during Friday’s pre-market trading session, drawing attention from investors and analysts alike. Pre-market trading often sets the tone for the regular
More
The FTSE 100 closed little changed as investors digested a stronger-than-expected US jobs report that reignited speculation about further Federal Reserve interest rate action. London’s blue-chip index struggled to find direction throughout
More
Ionis Pharmaceuticals has secured FDA approval for Zanvastro, marking a landmark moment as the first disease-modifying therapy ever cleared for Alexander disease. The approval arrived more than two weeks ahead of its
More
The U.S. House of Representatives returned from its August recess this week and moved swiftly to address one of Washington’s most pressing near-term deadlines. Lawmakers passed a stopgap funding bill to extend
More